Home > Financial Ratios > BIOCON

BIOCON
Working Capital/Sales

    Back to All Ratios
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 7.86-83.122.951.802.11

What is the latest Working Capital/Sales ratio of BIOCON ?

The latest Working Capital/Sales ratio of BIOCON is 7.86 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20257.86
Mar2024-83.12
Mar20232.95
Mar20221.80
Mar20212.11

How is Working Capital/Sales of BIOCON Trending?

Years Working Capital/Sales % Change
Mar2025 7.86
Positive
Mar2024 -83.12
Negative
Mar2023 2.95
63.89
Mar2022 1.8
-14.69
Mar2021 2.11 -

Other Financial Ratios of BIOCON


Compare Working Capital/Sales ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹57,995.8 Cr -0.1% -2.9% 8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,052.0 Cr 0.3% -3.7% -4.7% Stock Analytics
DIVIS LABORATORIES ₹169,336.0 Cr 2.4% 6.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,311.0 Cr -0.8% -1.5% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹111,264.0 Cr 7.9% 4.6% 4.6% Stock Analytics
CIPLA ₹105,484.0 Cr 5.5% 5.4% -18.5% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-0.1%

-2.9%

8%

SENSEX

-0.4%

1.3%

0.8%


You may also like the below Video Courses